Sophie Sun

3.2k total citations
73 papers, 1.6k citations indexed

About

Sophie Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sophie Sun has authored 73 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Sophie Sun's work include Cancer Genomics and Diagnostics (20 papers), BRCA gene mutations in cancer (19 papers) and Lung Cancer Treatments and Mutations (15 papers). Sophie Sun is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), BRCA gene mutations in cancer (19 papers) and Lung Cancer Treatments and Mutations (15 papers). Sophie Sun collaborates with scholars based in Canada, United States and Switzerland. Sophie Sun's co-authors include Peter G. Schultz, Jennifer L. Furman, Han Xiao, Abhishek Chatterjee, Chan Hyuk Kim, Kasmintan A. Schrader, Seihyun Choi, Yu Cao, Joan H. Schiller and Janessa Laskin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Sophie Sun

69 papers receiving 1.6k citations

Peers

Sophie Sun
Sandrine Aspeslagh Belgium
Ivan M. Blasutig Canada
Paola Orlandi Italy
Kari B. Wisinski United States
Michaela J. Higgins United States
Peter Ang Singapore
Toshima Z. Parris Sweden
Margaret M. Centenera Australia
Kathleen D. Whitney United States
Amen Sibtain United Kingdom
Sandrine Aspeslagh Belgium
Sophie Sun
Citations per year, relative to Sophie Sun Sophie Sun (= 1×) peers Sandrine Aspeslagh

Countries citing papers authored by Sophie Sun

Since Specialization
Citations

This map shows the geographic impact of Sophie Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Sun more than expected).

Fields of papers citing papers by Sophie Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Sun. The network helps show where Sophie Sun may publish in the future.

Co-authorship network of co-authors of Sophie Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Sun. A scholar is included among the top collaborators of Sophie Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Sun. Sophie Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sechidis, Konstantinos, et al.. (2025). Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity. Statistics in Medicine. 44(28-30). e70324–e70324.
2.
3.
Cornelissen, Robin, Arsela Prelaj, Sophie Sun, et al.. (2023). Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4). Journal of Thoracic Oncology. 18(8). 1031–1041. 34 indexed citations
4.
Li, Kelly, Ian Bosdet, Stephen Yip, et al.. (2023). Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Current Oncology. 30(8). 7099–7111. 1 indexed citations
5.
Wang, Peiyao, Sophie Sun, Stephen Lam, & William W. Lockwood. (2023). New insights into the biology and development of lung cancer in never smokers—implications for early detection and treatment. Journal of Translational Medicine. 21(1). 585–585. 7 indexed citations
6.
7.
Dixon, Katherine, Yaoqing Shen, Kieran O’Neill, et al.. (2023). Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing. European Journal of Human Genetics. 31(5). 602–606. 6 indexed citations
8.
Tsang, Erica S., Veronika Csizmók, Laura M. Williamson, et al.. (2023). Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration. npj Precision Oncology. 7(1). 31–31. 11 indexed citations
9.
Kwon, Janice S., Anna V. Tinker, Jennifer L. Santos, et al.. (2022). Germline Testing and Somatic Tumor Testing forBRCA1/2Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?. JCO Precision Oncology. 6(6). e2200033–e2200033. 8 indexed citations
10.
Yip, Stephen, Barbara Melosky, Cheryl Ho, et al.. (2022). Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study. Current Oncology. 30(1). 145–156. 2 indexed citations
11.
Titmuss, Emma, Alexandra Pender, James T. Topham, et al.. (2022). The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space. Journal of Molecular Diagnostics. 24(6). 609–618. 7 indexed citations
12.
Leung, Bonnie, Eric Berthelet, Janessa Laskin, et al.. (2022). 964P PACIFIC on the West Coast: Exploring reasons for not receiving consolidative durvalumab in the treatment of locally advanced lung cancer. Annals of Oncology. 33. S988–S988.
13.
Parker, Jeremy, Richard A. Moore, Tracy Tucker, et al.. (2021). Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition. Journal of Molecular Diagnostics. 23(9). 1145–1158. 2 indexed citations
14.
Hong, Quan, et al.. (2021). Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program. Familial Cancer. 21(3). 369–374. 12 indexed citations
15.
Siah, Kien Wei, Nicholas Kelley, Björn Holzhauer, et al.. (2021). Predicting drug approvals: The Novartis data science and artificial intelligence challenge. Patterns. 2(8). 100312–100312. 25 indexed citations
16.
Myers, Renelle, Michael Bräuer, Trevor Dummer, et al.. (2021). High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung Cancer. Journal of Thoracic Oncology. 16(11). 1850–1858. 40 indexed citations
17.
18.
Tsang, Erica S., Yaoqing Shen, Cheryl Ho, et al.. (2018). Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer. Molecular Case Studies. 5(1). a002659–a002659. 3 indexed citations
19.
Adjalla, Charles, Angela Hosack, Brian M. Gilfix, et al.. (1998). Seven novel mutations inmut methylmalonic aciduria. Human Mutation. 11(4). 270–274. 25 indexed citations
20.
Bignell, Graham R., Federico Canzian, Markus Stark, et al.. (1997). Familial Nontoxic Multinodular Thyroid Goiter Locus Maps to Chromosome 14q but Does Not Account for Familial Nonmedullary Thyroid Cancer. The American Journal of Human Genetics. 61(5). 1123–1130. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Aspeslagh Breakdown of academic impact, for papers by Ivan M. Blasutig Breakdown of academic impact, for papers by Paola Orlandi Breakdown of academic impact, for papers by Kari B. Wisinski Breakdown of academic impact, for papers by Michaela J. Higgins Breakdown of academic impact, for papers by Peter Ang Breakdown of academic impact, for papers by Toshima Z. Parris Breakdown of academic impact, for papers by Margaret M. Centenera Breakdown of academic impact, for papers by Kathleen D. Whitney Breakdown of academic impact, for papers by Amen Sibtain
Rankless by CCL
2026